Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kaiser Permanente

www.kaiserpermanente.org

Latest From Kaiser Permanente

When Will POC Really Be On The Cusp Of Major Uptake?

Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data via automation and IT means that progress might change at last. How the tests are paid for remains an issue. The future of POC was the theme of an investor discussion at the first DxPx conference, held during the Medica 2019 event in Germany.

Diagnostics Medical Device

Big Tech Helping US FDA With Sentinel Expansion

Amazon, Microsoft, IBM among those helping build new operations and innovation centers for the US FDA's safety surveillance system.

Drug Safety Post Market Regulation & Studies

Sanofi/Google Alliance To Apply Big Data To R&D, Commercial And Marketing Operations

Sanofi says the virtual innovation lab it will create with Google will enable precision health care and optimize R&D and commercial operations. Incoming CEO Hudson has been tasked with improving the pharma’s R&D and digital capabilities.

Deals Digital Health

Real-World Evidence: Observational Studies Deserve More Respect In US FDA Framework

Biopharma industry urges agency to open the door wider to use of non-randomized observational studies to support efficacy claims, but insurer Kaiser Permanente calls such studies problematic.

Drug Approval Standards Clinical Trials
See All

Company Information

UsernamePublicRestriction

Register